The Global Spasticity Treatment Market is projected to surge from USD 1.47 Billion in 2024 to USD 3.82 Billion by 2032, expanding at an 11.0% CAGR.
Driven by advancements in stroke recovery, pediatric cerebral palsy care, and expanding MS therapies, neuromuscular treatment is undergoing a major paradigm shift. Early intervention and targeted approaches are replacing passive, high-dose oral antispasmodics.
Gusto
Magkomento
Ibahagi
